Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Genet Med
2019 Dec 01;2112:2755-2764. doi: 10.1038/s41436-019-0576-0.
Show Gene links
Show Anatomy links
DYRK1A-related intellectual disability: a syndrome associated with congenital anomalies of the kidney and urinary tract.
Blackburn ATM
,
Bekheirnia N
,
Uma VC
,
Corkins ME
,
Xu Y
,
Rosenfeld JA
,
Bainbridge MN
,
Yang Y
,
Liu P
,
Madan-Khetarpal S
,
Delgado MR
,
Hudgins L
,
Krantz I
,
Rodriguez-Buritica D
,
Wheeler PG
,
Al-Gazali L
,
Mohamed Saeed Mohamed Al Shamsi A
,
Gomez-Ospina N
,
Chao HT
,
Mirzaa GM
,
Scheuerle AE
,
Kukolich MK
,
Scaglia F
,
Eng C
,
Willsey HR
,
Braun MC
,
Lamb DJ
,
Miller RK
,
Bekheirnia MR
.
???displayArticle.abstract???
PURPOSE: Haploinsufficiency of DYRK1A causes a recognizable clinical syndrome. The goal of this paper is to investigate congenital anomalies of the kidney and urinary tract (CAKUT) and genital defects (GD) in patients with DYRK1A variants.
METHODS: A large database of clinical exome sequencing (ES) was queried for de novo DYRK1A variants and CAKUT/GD phenotypes were characterized. Xenopus laevis (frog) was chosen as a model organism to assess Dyrk1a's role in renal development.
RESULTS: Phenotypic details and variants of 19 patients were compiled after an initial observation that one patient with a de novo pathogenic variant in DYRK1A had GD. CAKUT/GD data were available from 15 patients, 11 of whom presented with CAKUT/GD. Studies in Xenopus embryos demonstrated that knockdown of Dyrk1a, which is expressed in forming nephrons, disrupts the development of segments of embryonic nephrons, which ultimately give rise to the entire genitourinary (GU) tract. These defects could be rescued by coinjecting wild-type human DYRK1A RNA, but not with DYRK1AR205* or DYRK1AL245R RNA.
CONCLUSION: Evidence supports routine GU screening of all individuals with de novo DYRK1A pathogenic variants to ensure optimized clinical management. Collectively, the reported clinical data and loss-of-function studies in Xenopus substantiate a novel role for DYRK1A in GU development.
???displayArticle.pubmedLink???
31263215
???displayArticle.pmcLink???PMC6895419 ???displayArticle.link???Genet Med ???displayArticle.grants???[+]
Figure 2. In situ hybridization of dyrk1a across developmental stages demonstrates kidney expression in X. laevis and X. tropicalis.To demonstrate spatial-temporal expression of dyrk1a in the kidney, in situ hybridization was performed. Given that the RNA probe was designed against the X. tropicalis sequence, both species were analyzed. Pronephric kidney development occurs between stages 12.5-40. Expression of dyrk1a can be visualized in stage 31-40 embryos suggesting Dyrk1a may be important for kidney development. For clarity, insets (Dâ and Jâ) for stage 30/31 tadpole kidneys with 200μm scale bars have been added. All other scale bars represent 1000μm.
Figure 3. Loss of Dyrk1a affects kidney development in Xenopus laevis.(A-Eâ) Embryos were unilaterally injected at the 8-cell stage with 10ng of Dyrk1a MO or Standard MO (Std MO) along with 50 pg β-gal, wild-type, DYRK1AR205*, or DYRK1AL245R RNA. Stage 40 tadpoles were stained with kidney antibodies 3G8, which label the proximal tubules and 4A6, which labels the distal and connecting tubules. Letters without apostrophes (A-E) represent the injected side, whereas letters with apostrophes (Aâ-Eâ) represent the uninjected side. (B) Knockdown with a translation-blocking Dyrk1a MO disrupts kidney development which can be partially rescued (C) by co-injecting with wild-type human DYRK1A RNA but not (D-E) DYRK1AR205* or DYRK1AL245R RNA. (A) Co-injection of a Standard MO and β-gal serve as a negative control. Scale bars represent 100 μm. (F) The graph demonstrates a significant difference between embryos injected with either Dyrk1a MO + β-gal or Dyrk1a MO + DYRK1AR205* versus with Dyrk1a MO + DYRK1A suggesting successful rescue with human DYRK1A but not with the nonsense RNA. (G) The second graph demonstrates a significant difference between embryos injected with Dyrk1a MO + DYRK1AL245R versus with Dyrk1a MO + DYRK1A, which suggests that the missense RNA also fails to rescue. Significance was established against embryos that had a moderate or severe kidney phenotype (orange bar) and excluded embryos that had a weak phenotype (yellow bar). (F) * (asterisk) = p<0.001 comparing individual experimental groups to Standard MO + β-gal. # (pound sign) = p<0.006 comparing Dyrk1a MO + DYRK1A to Dyrk1a MO + DYRK1AR205*. (G) * (asterisk) = p<0.001 comparing Standard MO + β-gal to Dyrk1a MO + β-gal or Dyrk1a MO + DYRK1AL245R. # (pound sign) = p<0.05 comparing Dyrk1a MO + DYRK1A to Dyrk1a MO + DYRK1AL245R. For edema assays, embryos were injected at the 4-cell stage in both ventral cells to target both kidneys while avoiding the dorsal cells fated to become the heart and liver, which can also lead to edema. (H) Embryos injected with the Standard MO did not develop edema while embryos injected (I) with the Dyrk1a MO did develop edema and also suffered from abnormal kidney formation. (J) The graph demonstrates a significant difference in edema and kidney abnormalities in embryos injected with either Standard MO or Dyrk1a MO. * (asterisk) = p<0.008 comparing Standard MO to Dyrk1a MO embryos with edema, defects in one, and defects in both kidneys. Error bars represent standard error. For ease of comparison of (n) and p-values across conditions, please refer to Table S1-3.
Supplementary Figure 1. Human and Xenopus laevis protein alignment and short and long Xenopus homeolog alignment for dyrk1a 5âUTR. (A) Human DYRK1A mRNA transcript variant 1 (NM_001396.4) and Xenopus laevis dyrk1a short homeolog mRNA (NM_001163197.1) were translated and aligned using Clustal Omega. The overall identity between the protein sequences is 91.3% while the kinase domain has 97.5% identity demonstrating DYRK1A is highly conserved. Grey shading represents the kinase domain of DYRK1A. Symbols reflect Clustal Omegaâs analysis of the residues and examples of specific residue groups that reflect each symbol can be found at their website https://www.ebi.ac.uk/Tools/msa/clustalo/. An * (asterisk) indicates positions with a fully conserved residue. A : (colon) indicates conservation between groups of strongly similar properties. A . (period) indicates conservation between groups of weakly similar properties. DYRK1A encodes a protein of 763 or 754 amino acid residues which results from alternative splicing with the longer isoform representing the canonical sequence shown above. Xenopus is missing residues 70-78 which are the same residues the short isoform of human DYRK1A (754 amino acids) is missing. This suggests that Xenopus most likely expresses an isoform of DYRK1A that is orthologous to the short isoform (NM_001347721.2) in human. (B) Alignment of dyrk1aâs 5âUTR demonstrate in grey shading where the morpholino targets and that it hits both long and short homeologs in Xenopus. Underlined text represents the coding sequence of dyrk1a. The Dyrk1a morpholino was designed against the short homeolog of dyrk1a (top sequence), however, here it is shown it targets both the short and long (bottom sequence) (identified via a BLAT search of Crick http://genomes.crick.ac.uk/). The morpholino does not target dyrk1a.2 which appears to be a duplication of dyrk1a with amino acid conservation only maintained in the kinase domain.
Supplementary Figure 2. The Dyrk1a MO correctly targets Xenopus dyrk1a RNA and wild-type, missense, and truncated human DYRK1A proteins are expressed in neurula stage Xenopus embryos. Two constructs were generated with a GFP tag to demonstrate that the MO targets the endogenous 5â untranslated region (UTR) of dyrk1aâs transcript. (A, bottom) Schematic demonstrates that the 5â UTR construct contains part of dyrk1aâs endogenous (endo) 5â UTR that is recognized by the Dyrk1a MO (A, top) while the control construct does not. (B) Single-cell embryos were injected with 10 ng of either Dyrk1a MO or Standard MO (Std MO) and co-injected with 1 ng RNA (either Xenopus dyrk1a control, or Xenopus dyrk1a + 5â UTR). Western blot demonstrates complete reduction of GFP protein levels, indicative of loss of exogenous Dyrk1a in neurula stage embryos injected with Dyrk1a MO and dyrk1a + 5â UTR RNA (lane 5) compared to the Standard MO and dyrk1a + 5â UTR (lane 4) and Standard MO or Dyrk1a MO and dyrk1a control RNA (lane 2, lane 3). GAPDH was used as a loading control. (C) Wild-type human DYRK1A cDNA was inserted into a pCS2-HA vector. DYRK1AR205* and DYRK1AL245R variants were generated from the wild-type human pCS2-HA-DYRK1A vector. Western blot demonstrates HA protein is present in wild-type, missense (lanes 2 and 3 ~95 kDa), and truncated DYRK1AR205* (lane 4 ~25 kDa) lanes, demonstrating Xenopus neurula stage embryos can successfully translate human DYRK1A RNA. GAPDH was used as a loading control. Bar under the molecular weight indicates its position on the blot.
Supplementary Figure 3. Overexpressing DYRK1AR205* or DYRK1AL245R does not cause a gain-of-function phenotype. (A) Xenopus embryos were injected at the 8-cell stage with the rescue dose (50pg) of either ï¢-gal, wild-type DYRK1A, DYRK1AR205*, or DYRK1AL245R RNA. (B) No significant difference (p>0.7) was found between either ï¢-gal and wild-type DYRK1A, DYRK1AR205*, or DYRK1AL245R suggesting neither variant elicits a gain-of-function phenotype. It should be noted that some embryos injected with wild-type human DYRK1A RNA had slightly underdeveloped kidneys suggesting DYRK1A overexpression may also affect kidney development. Experiments were repeated three times with error bars representing standard error. The total number of Xenopus embryos are as follows: β-gal: 67, DYRK1A: 76, DYRK1AR205*: 88, DYRK1AL245R: 65. Scale bar represents 100 µm.
Supplementary Figure 4. Scoring system for Xenopus embryonic kidneys. Kidneys were scored at Nieuwkoop and Faber stage 40.12 (A) A normal kidney consists of three branches in the proximal region with a âtrunkâ connecting to the convoluted looping of the early distal region, and strong immunostaining of the late distal region. (B) A weak phenotype consists of loss of one of the branches in the proximal region and possibly less early distal looping and/or partial loss of late distal immunostaining. (C) A moderate phenotype consists of loss of two of the branches in the proximal region with moderate loss of early distal looping and possible loss of late distal immunostaining. (D) A severe phenotype consists of complete loss of proximal tubules with severe or complete loss of early distal looping and the late distal region. (E) The schematic represents a stereotypical Xenopus embryonic kidney with proximal tubules in light blue, distal tubules in blue, and connecting tubules in dark blue. Scale bar represents 100 µm.
Aranda,
DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles.
2011, Pubmed
Aranda,
DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles.
2011,
Pubmed
Arranz,
Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome.
2019,
Pubmed
Bainbridge,
Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities.
2011,
Pubmed
Bekheirnia,
Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene.
2017,
Pubmed
Blackburn,
Modeling congenital kidney diseases in Xenopus laevis.
2019,
Pubmed
,
Xenbase
Chatterjee,
Traditional and targeted exome sequencing reveals common, rare and novel functional deleterious variants in RET-signaling complex in a cohort of living US patients with urinary tract malformations.
2012,
Pubmed
Courcet,
The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
2012,
Pubmed
Davidson,
Integrin alpha5beta1 and fibronectin regulate polarized cell protrusions required for Xenopus convergence and extension.
2006,
Pubmed
,
Xenbase
Deciphering Developmental Disorders Study,
Large-scale discovery of novel genetic causes of developmental disorders.
2015,
Pubmed
DeLay,
Technique to Target Microinjection to the Developing Xenopus Kidney.
2016,
Pubmed
,
Xenbase
DeLay,
Dynamin Binding Protein Is Required for Xenopus laevis Kidney Development.
2019,
Pubmed
,
Xenbase
Evers,
Structural analysis of pathogenic mutations in the DYRK1A gene in patients with developmental disorders.
2017,
Pubmed
Gbadegesin,
TNXB mutations can cause vesicoureteral reflux.
2013,
Pubmed
Hong,
Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway.
2012,
Pubmed
,
Xenbase
Jansson,
Sex-dependent expression of anti-Müllerian hormone (amh) and amh receptor 2 during sex organ differentiation and characterization of the Müllerian duct development in Xenopus tropicalis.
2016,
Pubmed
,
Xenbase
Ji,
DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
2015,
Pubmed
Kobayashi,
Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development.
2005,
Pubmed
,
Xenbase
Lek,
Analysis of protein-coding genetic variation in 60,706 humans.
2016,
Pubmed
Lochhead,
Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.
2005,
Pubmed
Lupski,
Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy.
2013,
Pubmed
Møller,
Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.
2008,
Pubmed
Moody,
Segregation of fate during cleavage of frog (Xenopus laevis) blastomeres.
1990,
Pubmed
,
Xenbase
Morin,
Sequencing and analysis of 10,967 full-length cDNA clones from Xenopus laevis and Xenopus tropicalis reveals post-tetraploidization transcriptome remodeling.
2006,
Pubmed
,
Xenbase
Nestor,
Towards precision nephrology: the opportunities and challenges of genomic medicine.
2018,
Pubmed
Piprek,
Evolutionary trend for metamery reduction and gonad shortening in Anurans revealed by comparison of gonad development.
2014,
Pubmed
,
Xenbase
Raciti,
Organization of the pronephric kidney revealed by large-scale gene expression mapping.
2008,
Pubmed
,
Xenbase
Richards,
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
2015,
Pubmed
Romagnani,
Renal progenitors: an evolutionary conserved strategy for kidney regeneration.
2013,
Pubmed
Sanna-Cherchi,
Mutations in DSTYK and dominant urinary tract malformations.
2013,
Pubmed
Sive,
Isolation of DNA from red blood cells in Xenopus.
2012,
Pubmed
,
Xenbase
van Bon,
Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
2016,
Pubmed
van der Ven,
Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract.
2018,
Pubmed
Vize,
Development of the Xenopus pronephric system.
1995,
Pubmed
,
Xenbase
Widowati,
Functional characterization of DYRK1A missense variants associated with a syndromic form of intellectual deficiency and autism.
2018,
Pubmed
Woolf,
A molecular and genetic view of human renal and urinary tract malformations.
2000,
Pubmed
Zhou,
Proximo-distal specialization of epithelial transport processes within the Xenopus pronephric kidney tubules.
2004,
Pubmed
,
Xenbase